Clinical trial
An Observational Study in Patients With Indolent Systemic Mastocytosis
NCT07264959 is registered in ClinicalTrials.gov with Blueprint Medicines Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Observational Study in Patients With Indolent Systemic Mastocytosis
- Lead sponsor
- Blueprint Medicines Corporation
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- April 15, 2026
- Completion date
- December 1, 2032
- Enrollment
- 150 (estimated)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
indolent systemic mastocytosis